NO20001412D0 - Compositions and Methods in the Treatment of Respiratory Disorders - Google Patents

Compositions and Methods in the Treatment of Respiratory Disorders

Info

Publication number
NO20001412D0
NO20001412D0 NO20001412A NO20001412A NO20001412D0 NO 20001412 D0 NO20001412 D0 NO 20001412D0 NO 20001412 A NO20001412 A NO 20001412A NO 20001412 A NO20001412 A NO 20001412A NO 20001412 D0 NO20001412 D0 NO 20001412D0
Authority
NO
Norway
Prior art keywords
compositions
treatment
methods
respiratory disorders
respiratory
Prior art date
Application number
NO20001412A
Other languages
Norwegian (no)
Inventor
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20001412D0 publication Critical patent/NO20001412D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20001412A 1997-09-19 2000-03-17 Compositions and Methods in the Treatment of Respiratory Disorders NO20001412D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93403397A 1997-09-19 1997-09-19
PCT/IB1998/001339 WO1999015173A1 (en) 1997-09-19 1998-08-28 Compositions and methods for treating respiratory disorders

Publications (1)

Publication Number Publication Date
NO20001412D0 true NO20001412D0 (en) 2000-03-17

Family

ID=25464848

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001412A NO20001412D0 (en) 1997-09-19 2000-03-17 Compositions and Methods in the Treatment of Respiratory Disorders

Country Status (12)

Country Link
EP (1) EP1014983A1 (en)
JP (1) JP2001517626A (en)
KR (1) KR20010024187A (en)
CN (1) CN1278728A (en)
AU (1) AU8744398A (en)
BR (1) BR9812660A (en)
CA (1) CA2304005A1 (en)
CO (1) CO5011084A1 (en)
HU (1) HUP0004813A2 (en)
NO (1) NO20001412D0 (en)
PE (1) PE118999A1 (en)
WO (1) WO1999015173A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004508324A (en) * 2000-09-08 2004-03-18 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー Prevent acute sinusitis and sinus attacks
BR0210534A (en) * 2001-06-20 2004-06-22 Schering Corp Antihistamines for the treatment of nasal congestion and nasal obstruction
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
TWI313598B (en) 2002-12-18 2009-08-21 Wyeth Corp Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US20050192355A1 (en) * 2004-02-17 2005-09-01 Wyeth Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
CN101073563B (en) * 2007-02-07 2010-10-06 西安利君制药有限责任公司 Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet
GB0719518D0 (en) * 2007-10-05 2007-11-14 Therapeutics Ltd E Therapy
CA2750196C (en) * 2009-01-05 2017-06-20 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
WO2010078543A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing cetirizine pseudoephedrine, and naproxen containing a barrier layer
CA2748783A1 (en) 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
GB0905954D0 (en) * 2009-04-06 2009-05-20 E Therapeutics Plc Treatment of exacerbations of asthma
CN103446587A (en) * 2011-12-28 2013-12-18 汪明 Application of mastocyte inhibitor in preparation of medicine for resisting influenza virus infection
CN103251590B (en) * 2013-05-13 2014-12-17 中国科学院武汉病毒研究所 Application of doxylamine succinate in preparing drug for treating or preventing influenza virus
EP3273952B1 (en) 2015-03-26 2022-06-15 Sen-Jam Pharmaceutical LLC Combination of naproxen and fexofenadine to inhibit symptoms associated with veisalgia
CN109464670B (en) * 2017-09-08 2022-08-02 中国科学院微生物研究所 Key amino acid site for regulating and controlling nucleoprotein nuclear production of influenza A virus and influenza B virus and application of key amino acid site as anti-influenza virus drug target

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5260073A (en) * 1990-05-21 1993-11-09 Norwich Eaton Pharmaceuticals, Inc. Use of phenylpropanolamine as a mucus secretogogue in the upper airways
CN1130354A (en) * 1993-09-07 1996-09-04 普罗克特和廿保尔公司 Compositions containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant an expectorant, an antihistamine and an antitussive
WO1997004808A1 (en) * 1995-07-28 1997-02-13 The Procter & Gamble Company Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders

Also Published As

Publication number Publication date
AU8744398A (en) 1999-04-12
CO5011084A1 (en) 2001-02-28
HUP0004813A2 (en) 2001-08-28
CA2304005A1 (en) 1999-04-01
WO1999015173A1 (en) 1999-04-01
BR9812660A (en) 2000-08-22
CN1278728A (en) 2001-01-03
EP1014983A1 (en) 2000-07-05
PE118999A1 (en) 2000-02-03
JP2001517626A (en) 2001-10-09
KR20010024187A (en) 2001-03-26

Similar Documents

Publication Publication Date Title
NO972972D0 (en) Compositions for the treatment of dermatological disorders and methods for their use
NO20004098D0 (en) Methods and preparations for the treatment of macrophage-mediated disorders
NO20001754L (en) Prostaglandin agonists and their use in the treatment of bone disorders
NO20002846L (en) Inhalation device and method of the same
NO992641D0 (en) Mixtures and Methods for the Treatment or Prevention of Inflammatory Diseases
PL348817A1 (en) Compositions and methods for the treatment of anorectal disorders
NO994778D0 (en) Methods and compositions for the treatment of intestinal inflammation
EP1005345A4 (en) Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
EP0963219A4 (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
GB2334444B (en) Hair treatment composition and method of manufacturing the composition
FI971969A0 (en) Compositions and method of use for the treatment of hemorrhoids
NO994014D0 (en) Arylsulfonamides and analogs thereof and their use in the treatment of neurodegenerative diseases
NO20001412D0 (en) Compositions and Methods in the Treatment of Respiratory Disorders
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
EP0924983A4 (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
IL125446A0 (en) Pharmaceutical composition for the treatment of asthma allergy and inflammation
NO984836D0 (en) Substituted benzylamines and their use in the treatment of depression
NO972426D0 (en) Method for the use of triarylethylene derivatives in the treatment and prevention of osteoporosis
EP1030663A4 (en) Treatment of fibromyalgia and related disorders
IL114119A0 (en) Compositions and methods for the treatment of tumors
NO20010464D0 (en) Methods and compositions for the treatment of gastroesophrageal reflux syndrome
NO20001758D0 (en) Methods and compositions for the treatment of arthritis
ZA981781B (en) The use of levobupivacaine in treating migraine
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases